Table 1.
Serum cortisol (nmol/L) | Study population | Total | |||
---|---|---|---|---|---|
| |||||
OSMF | OLP | Leukoplakia | Control | ||
≤200 | 25 | 10 | 36 | 49 | 120 |
≥201-≤400 | 34 | 36 | 25 | 20 | 115 |
≥401-≤600 | 11 | 21 | 09 | 01 | 42 |
≥601-≤800 | 00 | 03 | 00 | 00 | 03 |
Serum cortisol (nmol/L) | Study population | Total | |||
---|---|---|---|---|---|
| |||||
OSMF | OLP | Leukoplakia | Control | ||
≤200 | 25 | 10 | 36 | 49 | 120 |
≥201-≤400 | 34 | 36 | 25 | 20 | 115 |
≥401-≤600 | 11 | 21 | 09 | 01 | 42 |
≥601-≤800 | 00 | 03 | 00 | 00 | 03 |